Pliant Therapeutics Inc.
PLRX | NASDAQ
$0.85
-$0.01 (-1.04%)
Nov 2, 2026, 10:36 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 248K | 1.33M | 1.97M | 1.48M | 4.99M | 1.25M | 2M | 1.61M | 1.79M | 2.17M |
Cost of Revenue | n/a | 264K | n/a | n/a | 447K | n/a | n/a | n/a | 622K | 513K | n/a | n/a | 1.1M | 1.06M | 1.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -264K | n/a | n/a | -447K | n/a | n/a | n/a | -622K | -513K | n/a | n/a | -856K | 271K | 912K | 1.48M | 4.99M | 1.25M | 2M | 1.61M | 1.79M | 2.17M |
Operating Income | -23.86M | -21.77M | -23.58M | -28.27M | -45.59M | -58.94M | -53.32M | -62.01M | -60.64M | -52.39M | -47.04M | -47.69M | -47.33M | -42.1M | -37.4M | -31.95M | -29.64M | -28.21M | -24.6M | -27.11M | -22.9M | -22.92M |
Interest Income | n/a | 1.73M | 1.96M | 2.78M | 3.1M | 3.57M | 4.42M | 5.13M | 5.65M | 5.88M | 6.25M | 6.52M | 6.46M | 4.86M | 2.66M | 1.63M | 269K | 111K | 68K | 68K | 73K | 63K |
Pretax Income | -22.37M | -20.04M | -23.58M | -26.3M | -43.3M | -56.17M | -49.73M | -57.76M | -55.85M | -46.96M | -41.11M | -41.49M | -41.19M | -37.55M | -35.06M | -30.62M | -29.55M | -28.1M | -24.53M | -27.05M | -22.83M | -22.86M |
Net Income | -22.37M | -20.04M | -23.58M | -26.3M | -43.3M | -56.17M | -49.73M | -57.76M | -55.85M | -46.96M | -41.11M | -41.49M | -41.19M | -37.55M | -35.06M | -30.62M | -29.55M | -28.1M | -24.53M | -27.05M | -22.83M | -22.86M |
Selling & General & Admin | 7.14M | 8.19M | 7.69M | 10.33M | 13.39M | 15.5M | 14.53M | 14.26M | 15.02M | 15.25M | 13.85M | 15.35M | 14.57M | 14.15M | 14.25M | 8.82M | 8.3M | 8.58M | 7.85M | 7.67M | 5.48M | 6.57M |
Research & Development | 16.73M | 13.32M | 15.59M | 17.94M | 32.2M | 43.44M | 38.79M | 47.75M | 45M | 36.63M | 33.18M | 32.34M | 31.9M | 28.21M | 24.06M | 24.61M | 26.34M | 20.88M | 18.75M | 21.05M | 19.22M | 18.53M |
Other Expenses | n/a | n/a | 300K | n/a | -447K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 23.86M | 21.51M | 23.58M | 28.27M | 45.15M | 58.94M | 53.32M | 62.01M | 60.02M | 51.88M | 47.04M | 47.69M | 46.47M | 42.37M | 38.31M | 33.43M | 34.63M | 29.46M | 26.6M | 28.72M | 24.69M | 25.09M |
Interest Expense | n/a | n/a | 136K | 815K | 809K | 799K | 834K | 877K | 868K | 445K | 321K | 317K | 319K | 311K | 317K | 301K | 173K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23.86M | 21.77M | 23.58M | 28.27M | 45.59M | 58.94M | 53.32M | 62.01M | 60.64M | 52.39M | 47.04M | 47.69M | 47.58M | 43.43M | 39.37M | 33.43M | 34.63M | 29.46M | 26.6M | 28.72M | 24.69M | 25.09M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 61.92M | 61.8M | 61.37M | 61.41M | 61.39M | 61.22M | 60.54M | 60.73M | 60.38M | 60.18M | 59.9M | 59.69M | 59.17M | 56.06M | 48.78M | 46.8M | 36.17M | 36.03M | 36.02M | 35.91M | 35.67M | 35.65M |
Shares Outstanding (Diluted) | 61.92M | 61.8M | 61.37M | 61.41M | 61.39M | 61.22M | 60.54M | 60.73M | 60.38M | 60.18M | 59.9M | 59.69M | 59.17M | 56.06M | 48.78M | 46.8M | 36.17M | 36.12M | 36.02M | 35.91M | 35.75M | 35.65M |
EPS (Basic) | -0.36 | -0.32 | -0.38 | -0.43 | -0.71 | -0.92 | -0.82 | -0.95 | -0.92 | -0.78 | -0.69 | -0.70 | -0.70 | -0.50 | -0.71 | -0.60 | -0.82 | -0.77 | -0.68 | -0.75 | -0.64 | -0.64 |
EPS (Diluted) | -0.36 | -0.32 | -0.38 | -0.43 | -0.71 | -0.92 | -0.82 | -0.95 | -0.92 | -0.78 | -0.69 | -0.70 | -0.70 | -0.50 | -0.71 | -0.60 | -0.82 | -0.77 | -0.68 | -0.75 | -0.64 | -0.64 |
EBITDA | -22.17M | -19.78M | -23.08M | -23.08M | -42.04M | -54.92M | -48.44M | -56.35M | -54.36M | -46M | -40.32M | -40.72M | -39.77M | -36.18M | -33.72M | -29.86M | -28.91M | -27.65M | -24.11M | -26.66M | -22.46M | -22.56M |
EBIT | -22.37M | -20.04M | -23.44M | -23.52M | -42.49M | -55.37M | -48.9M | -56.89M | -54.99M | -46.51M | -40.79M | -41.17M | -40.87M | -37.24M | -34.77M | -30.31M | -29.37M | -28.1M | -24.53M | -27.05M | -22.83M | -22.92M |
Depreciation & Amortization | 200K | 264K | 365K | 436K | 447K | 448K | 458K | 532K | 622K | 513K | 464K | 448K | 1.1M | 1.06M | 1.05M | 454K | 459K | 455K | 418K | 388K | 370K | 359K |
Add to Watchlist
Select watchlists to add or remove PLRX